Related by context. All words. (Click for frequent words.) 72 q#h 71 lopinavir r 70 #mg/m# [001] 70 #mg/m# [002] 70 administered subcutaneously 70 #mg/kg [002] 70 #mg BID [003] 70 mg m² 69 mg/m2 IV 69 mcg kg 69 8mg/kg 69 mg QD 69 4mg/kg 69 FOLFIRI 68 mg TID 68 saline placebo 68 FOLFOX4 alone 68 mg/m2/day 68 Peg IFN 68 mg subcutaneously 68 μg dose 67 mg/m2 67 IV bolus 67 peginterferon alfa 2b 67 achieved ACR# 67 FOLFOX6 66 abacavir lamivudine 66 FOLFOX 66 budesonide pMDI 66 #.#g/day 66 alfa 2a 66 mcg BID 66 placebo intravenously 66 ritonavir boosted atazanavir 66 oxycodone CR 66 interferon alfa 2a 66 mg BID 66 comparator arm 66 lopinavir r arm 66 plus methotrexate 66 Acetate Rectal Suppositories 66 lispro 66 #.#mg/dL 65 Peginterferon Alfa 2a 65 3mg/kg 65 mcg albinterferon alfa 2b 65 #mg QD [002] 65 5 FU leucovorin 65 peginterferon alfa 2a 65 dacarbazine 65 tolterodine ER 65 subcutaneous enoxaparin 65 mg simvastatin 65 piperacillin tazobactam 65 FOLFIRI alone 65 dosing intervals 65 mg qd 65 postmenopausal osteoporotic women 65 interferon alfa 2b 65 pegylated interferon alfa 2a 65 certolizumab 65 CIMZIA TM 65 8mg 65 carboplatin paclitaxel 65 mcg QD 64 mg administered orally 64 mg m 64 Capecitabine 64 cyclophosphamide methotrexate 64 fluorouracil 64 mg/m2 administered 64 Folfox 64 #mg BID [001] 64 #mg q8h 64 q8h 64 adriamycin 64 5-FU/LV 64 rizatriptan 64 ritonavir boosted 64 infliximab monotherapy 64 5FU 64 Copegus ribavirin 64 μg kg 64 FOLFOX4 64 plus MTX 64 cisplatin gemcitabine 64 LANTUS R 64 mg orally 64 Peginterferon 64 peginterferon alfa 2a Pegasys 63 log# copies mL 63 LPV r 63 FOLPI 63 Alkeran 63 neutropenia dehydration dyspnea 63 mcg mL 63 plus prednisone prednisolone 63 ug kg 63 Pegasys ® 63 R adefovir dipivoxil 63 achieved statistical significance 63 mcg Albuferon 63 mcg doses 63 #mg/day [002] 63 plus prednisone 63 Locteron administered 63 mg ustekinumab 63 cyclophosphamide doxorubicin vincristine 63 irbesartan 63 estramustine 63 oral allopurinol 63 FUSILEV enhances 63 ethambutol 63 severe neutropenia 63 daunorubicin 63 active comparator 63 plus ribavirin 63 oral rivaroxaban 63 1mg 2mg 63 doxorubicin cyclophosphamide 63 Pegasys plus Copegus 63 pegylated interferon alpha 63 low dose cytarabine 63 Prograf ® 62 nicardipine 62 PegIFN 62 biphasic insulin aspart 62 Epoetin Alfa 62 tobramycin inhalation solution 62 #mg doses [002] 62 darbepoetin alfa 62 mg q8h 62 mg subcutaneous 62 cisplatin vinorelbine 62 log# IU mL 62 Flu Cy 62 ribavirin RBV 62 chlorambucil 62 PEGASYS ® 62 ribavirin therapy 62 PEGylated anti 62 intravenous bolus 62 insulin detemir 62 subcutaneous injections 62 subcutaneous doses 62 docetaxel chemotherapy 62 fluticasone furoate 62 CHOP chemotherapy 62 #.#mg/kg [002] 62 mitoxantrone plus 62 #mg/day [001] 62 nadroparin 62 peg IFN 62 ceftazidime 62 PEG IFN 62 pyrexia mucositis sepsis febrile 62 doxazosin 62 5 Fluorouracil 62 #mg/#mg 62 adjunctive placebo 62 dalteparin 62 mitoxantrone 62 pegylated liposomal doxorubicin 62 inhalations twice 62 Pegasys peginterferon alfa 2a 62 mg/# hours 62 oxycodone IR 62 microgram kg 62 azathioprine 62 events AEs 62 SPRYCEL ® 62 fluticasone salmeterol 62 telaprevir dosed 62 intravenous dosing 62 oral vancomycin 62 dosing cohorts 62 ascending doses 62 idarubicin 62 Viread Emtriva 62 cytarabine daunorubicin 61 mcg 61 Pegylated Liposomal Doxorubicin 61 aspirin heparin 61 stage IIIb IV 61 laboratory abnormalities 61 timepoints 61 #/#.# mcg 61 glimepiride 61 ATACAND 61 evaluating Xcytrin 61 COPEGUS 61 DOXIL 61 mg eq 61 Camptosar ® 61 #μg [002] 61 Gemcitabine 61 PEG Intron 61 salmeterol fluticasone 61 Taxotere R 61 FOLPI regimen 61 progression TTP 61 Pharmacokinetics PK 61 injected subcutaneously 61 epoetin alpha 61 hematological parameters 61 REYATAZ r arm 61 flutamide 61 mg dosed 61 unresectable HCC 61 #mg #mg #mg [003] 61 plus glycoprotein IIb 61 Median PFS 61 LEXIVA r 61 mcg dose 61 ascending dose 61 VELCADE melphalan 61 administered orally 61 fluorouracil leucovorin 61 pharmacologically active isomer 61 generalized edema 61 TDF FTC 61 atazanavir ritonavir 61 dexamethasone Decadron 61 nevirapine Viramune 61 PREZISTA ritonavir 61 3mg 61 biologic DMARD 61 Irinotecan 61 valsartan amlodipine 61 mg subcutaneous injection 61 TAXOTERE R 61 headache nasopharyngitis 61 peginterferon alfa 2a #KD 61 melphalan prednisone 61 #/#mg 61 AZT zidovudine Retrovir 61 HBeAg seroconversion 61 dosed orally 61 QD dosing 61 PREZISTA r 61 prednisone prednisolone plus 61 p = NS 61 titrated glipizide plus 61 mg dosed twice 61 epoetin alfa 61 Engerix B 61 mg kg IV 61 peginterferon alpha 2a 61 placebo p = 61 highly emetogenic 61 mg Androxal 60 ALVESCO 60 biochemical relapse 60 epoetin beta 60 cyclophosphamide vincristine 60 PRN FDA Approves 60 insulin glulisine 60 TPV r 60 receiving INTRON 60 efavirenz EFV 60 administered concomitantly 60 Elitek 60 relapsed MM 60 Zometa hazard 60 NovoLog ® Mix 60 dose regimens 60 anthracycline taxane 60 placebo dexamethasone 60 mg kg intravenously 60 clodronate 60 dasatinib Sprycel ® 60 hydroxymethyl coenzyme 60 SVR# 60 plus GP IIb 60 mometasone furoate 60 titrated glipizide 60 dosage regimens 60 ALT normalization 60 placebo PBO 60 IU ml 60 nadolol 60 tenofovir emtricitabine 60 rFSH 60 ribavirin USP 60 tirofiban 60 olanzapine risperidone 60 amprenavir 60 5mg/kg 60 Pred Forte 60 cyclophosphamide doxorubicin 60 #mg ritonavir 60 bolus injection 60 mycophenolate mofetil 60 mg/m2 dose 60 ® zoledronic acid 60 ug dose 60 candesartan cilexetil 60 PROCTOCORT ® Suppository Hydrocortisone 60 daily subcutaneous injections 60 plus COPEGUS 60 Lamictal XR 60 PRADAXA #mg 60 Fluorouracil 60 mg tid 60 alpha interferons 60 #mg QD [001] 60 ceftriaxone 60 Copegus 60 achieved PASI 60 abacavir sulfate lamivudine 60 intramuscularly 60 CCyR 60 Omacetaxine mepesuccinate 60 Mg Uk 60 COMBIVIR 60 DLTs 60 Navelbine 60 interferon alfa 60 dapagliflozin plus 60 pill containing benazepril 60 adalimumab 60 antithymocyte globulin 60 intravitreal injection 60 docetaxel Taxotere ® 60 weekly subcutaneous injections 60 fosamprenavir 60 TEAEs 60 irinotecan doxorubicin oxaliplatin paclitaxel 60 bolus dose 60 inhaled fluticasone 60 placebo p 60 mg kg 60 hypomagnesemia 60 administered intramuscularly 60 mg kg dose 60 Mg Usa 60 valacyclovir 60 #mg ATC 60 IV DHE 60 PEGINTRON TM 60 nab paclitaxel 60 subcutaneously administered 60 Monotherapy 59 hypokalemia 59 dosing cohort 59 erlotinib Tarceva ® 59 pamidronate 59 APTIVUS r 59 miconazole 59 patients receiving ERBITUX 59 Zorbtive TM 59 6 mercaptopurine 59 Hypersensitivity reactions 59 risedronate Actonel 59 3TC lamivudine Epivir 59 REYATAZ r 59 nasopharyngitis 59 diuretic chlorthalidone 59 continuous intravenous infusion 59 Apidra ® 59 plus dexamethasone 59 lumbar spine BMD 59 IXEMPRA 59 radiotherapy RT 59 μmol L 59 ACTEMRA TM 59 triamcinolone 59 deferoxamine 59 beclomethasone dipropionate 59 PREMPRO 59 Xeloda ® 59 desvenlafaxine succinate 59 metformin XR 59 naïve HCV 59 sorafenib Nexavar 59 mg d 59 receiving prophylactic anticoagulation 59 R# #mg BID 59 rifapentine 59 5 fluorouracil 59 mg dose 59 #Gy 59 Daptomycin 59 TO AVOID PREGNANCY WHILE 59 ara C 59 Median progression 59 non splenectomized 59 Fludara 59 imipenem 59 q# 59 intravenous bolus injection 59 nucleoside analog 59 FEMALES SHOULD BE ADVISED 59 OADs 59 XELOX 59 Cream USP 1 59 refractory NSCLC 59 timolol 59 RLAI 59 potent CYP#A# inhibitors 59 Peginterferon alfa 2a 59 #mg BID [002] 59 voriconazole 59 oral antidiabetic medication 59 metastatic GIST 59 pioglitazone HCl 59 PegIFN RBV 59 oral ribavirin 59 EGFR TKI 59 fluticasone propionate FP 59 glulisine 59 Prograf R 59 atorvastatin #mg 59 Cyclophosphamide 59 ABC/3TC 59 plus gemcitabine 59 amphotericin B 59 fluoropyrimidine 59 Epoetin alfa 59 Diovan HCT 59 noninferior 59 ® lenalidomide 59 epirubicin cyclophosphamide 59 #ug [001] 59 R Saizen R 59 Pegylated interferon 59 Pegylated Interferon 59 IIIa inhibitor 59 fallopian tube carcinoma 59 alfa 2b 59 Indacaterol 59 PROCTOCORT R Cream Hydrocortisone 59 Ovitrelle R Serostim 59 partial remissions 59 mL/min/#.# m2 59 randomized #:# 59 NeoRecormon 59 primary hypercholesterolemia 59 budesonide formoterol 59 dose cytarabine 59 trandolapril 59 amoxicillin clavulanate 59 benazepril 59 log# 59 #.#/#.# mmHg [001] 59 Leucovorin 59 lenalidomide Revlimid R 59 vapreotide acetate 59 Median survival 59 R darbepoetin alfa 59 relapsed CLL 58 glargine 58 BARACLUDE ® 58 incidence ≥ 58 placebo 58 TMP SMX 58 Certolizumab 58 Adjuvant Treatment 58 6mg 58 mg/# mg [002] 58 aspartate aminotransferase 58 zidovudine lamivudine 58 NPH insulin 58 Tarceva TM 58 unfractionated heparin UFH 58 fluticasone 58 formoterol fumarate 58 mitomycin 58 capecitabine Xeloda 58 Etoposide 58 CAELYX 58 transaminase elevations 58 zolmitriptan 58 refractory chronic lymphocytic 58 octreotide LAR 58 -#.# log# copies mL 58 cells uL 58 lenalidomide dexamethasone 58 EPIVIR 58 alpha 2a 58 Fluticasone 58 Hycamtin ® 58 Hormone Refractory Prostate Cancer 58 Plus Ribavirin 58 discontinuations due 58 inhaled corticosteroid ICS 58 oral prednisone 58 #/#.# mg 58 ibandronate 58 adalimumab Humira 58 metformin sulfonylurea 58 pegylated interferon alfa 2b 58 oxaliplatin Eloxatin 58 cyclophosphamide 58 unfractionated heparin 58 enalapril 58 Taxotere ® 58 Roche Pegasys 58 Cutaneous T 58 inactive placebo 58 plus OBT 58 Medoxomil 58 sirolimus stent 58 daily Infergen 58 â ‰ ¥ 58 oral diclofenac 58 balsalazide 58 detectable HCV RNA 58 mg RDEA# 58 Peginterferon alfa 2b 58 mCi 58 Investigational Oral 58 intermittent dosing 58 LEXIVA 58 SMZ TMP 58 trastuzumab Herceptin R 58 oral alendronate 58 aspirin clopidogrel 58 cyclophosphamide AC 58 receiving VELCADE 58 pg mL 58 Lantus R 58 glatiramer acetate 58 sirolimus eluting stent 58 DOXIL ® 58 aplastic anemia AA 58 COZAAR 58 colesevelam HCl 58 Complicated Skin 58 μg doses 58 intradermal injections 58 bevacizumab Avastin R 58 subcutaneous dose 58 ketorolac 58 mg/# h 58 Fulvestrant 58 teriflunomide 58 tenofovir disoproxil fumarate 58 zoledronate 58 Posaconazole 58 lopinavir ritonavir plus 58 IFN α 58 HBeAg negative patients 58 administered intranasally 58 oral levofloxacin 58 tigecycline 58 FluCAM arm 58 vinorelbine 58 ORENCIA ® 58 Naive Patients 58 paclitaxel carboplatin 58 QTcF 58 Known hypersensitivity 58 pegylated interferon alfa 58 MIRCERA 58 monotherapy 58 kilogram mg kg 58 BENICAR 58 CsA 58 leucopenia 58 cetuximab Erbitux R 58 standard chemotherapy regimen 58 Orally administered 58 receiving ISENTRESS 58 albiglutide 58 Metformin HCl 58 #mg dose [003] 58 dose cohort 58 Pemetrexed 58 pegylated interferon 58 spontaneous bowel movements 58 brand ciclesonide HFA 58 ribavirin Copegus 58 statin monotherapy 58 administered intradermally 58 HBeAg positive 58 tacrolimus ointment 58 tamoxifen Nolvadex ® 58 paclitaxel cisplatin 58 oblimersen 58 mitoxantrone chemotherapy 58 Vidaza azacitidine 58 serum phosphorus 58 Adefovir 58 denileukin diftitox 58 clopidogrel Plavix 58 febrile neutropenia 58 baminercept 58 CIMZIA TM certolizumab pegol 58 Ondansetron Injection USP 58 recurrent metastatic 58 Durezol 58 treatment emergent adverse 57 thalidomide Thalomid 57 emtricitabine tenofovir 57 ARCOXIA 57 CIMZIA ™ 57 PEG Interferon alfa 57 leukopenia 57 irinotecan containing 57 intravenous REOLYSIN 57 mapatumumab 57 Doxil ® 57 -#.# log# 57 goserelin 57 Platinol 57 ciprofloxacin hydrochloride 57 microgram mcg 57 IFN alfa 57 pyrazinamide 57 clotrimazole 57 prednisone VcMP 57 Vinorelbine 57 alkylating agent 57 FIRMAGON 57 PEGylated Fab fragment 57 ug mL 57 -#.# ± [002] 57 insulin glargine 57 Ramipril 57 alanine aminotransferase 57 Single Dose 57 beta2 agonist 57 mg/# hr 57 esomeprazole 57 #mg doses [001] 57 TNF Tumor Necrosis Factor 57 Losartan Potassium 57 KOMBIGLYZE XR 57 fluticasone propionate 57 pegylated interferon alpha 2a 57 metformin hydrochloride 57 #mg tablet [001] 57 virologic failure 57 bendamustine ifosfamide 57 malignancy HCM 57 lumbar spine bone 57 Tipranavir 57 #mg dosing 57 mesalazine 57 salmeterol inhalation powder 57 q#d 57 lixisenatide 57 Copegus ® 57 Randomized Phase 57 COPEGUS R 57 somatostatin analog 57 NOLVADEX 57 achieved sustained virologic 57 DU #b 57 gemcitabine carboplatin 57 intravitreal injections 57 PROCTOCORT R 57 Atripla combines 57 Hazard Ratio 57 sufentanil 57 oral olanzapine 57 telaprevir dosing 57 Taxus Stent 57 nevirapine NVP 57 TAXUS p value 57 doxorubicin docetaxel 57 aminotransferase elevations greater 57 mg q#h 57 TRIZIVIR 57 Platinol ® cisplatin 57 HCV Genotype 57 ALT flares 57 micrograms mcg 57 IIIa inhibitors 57 Raptiva r 57 subcutaneous dosing 57 rabeprazole 57 galiximab 57 ARB telmisartan 57 GP IIb IIIa inhibitors 57 HBeAg positive patients 57 PEG Intron ® 57 μg mL 57 interferon beta 1a infertility 57 ZIAGEN 57 intravenous infusion 57 trimethoprim sulfamethoxazole 57 tenofovir Viread 57 mesalamine 57 lispro alone 57 Orally Disintegrating Tablets 57 gout flares 57 R tenofovir disoproxil 57 taxane chemotherapy 57 dexamethasone 57 CR nPR 57 Paraplatin ® 57 bisoprolol 57 Contrave# 57 dacarbazine DTIC 57 darunavir ritonavir 57 uM 57 sunitinib Sutent ® 57 ciclesonide 57 P = .# 57 timepoint 57 ULORIC 57 peginterferon 57 interferon ribavirin 57 adefovir 57 difluprednate 57 prednisone CHOP 57 oral clodronate 57 Aptivus ® 57 % CI #.#-#.# [003] 57 tiotropium bromide 57 serum phosphorous 57 treatment naive genotype 57 azacytidine 57 PSA nadir 57 Lantus ® 57 zonisamide SR 57 folinic acid 57 LIALDA 57 Xelox 57 tamsulosin 57 topical gel formulation 57 paclitaxel Taxol 57 R bisoprolol Euthyrox 57 intravenous IV infusion 57 peginterferon alfa 57 evaluating tivozanib 57 Free Survival PFS 57 + PH# 57 sitagliptin Januvia 57 HES CEL 57 interferon alpha Severe 57 benzoic acid hyoscyamine sulfate 57 5mg #mg 57 ribavirin Copegus ® 57 chemoradiation therapy 57 divalproex sodium 57 imatinib Gleevec ® 57 lanthanum carbonate 57 mcg linaclotide 57 R ribavirin USP 57 #mg [003] 57 yearly subcutaneous injections 57 Neulasta ® 57 melphalan 57 FluCAM 57 #mg #mg [002] 57 hypophosphatemia 57 microg 57 carboplatin AUC 6 57 severe renal impairment 57 tipranavir r 57 HCTZ 57 tenofovir FTC 57 pegylated alpha interferon 57 steroid dexamethasone 57 budesonide 57 coadministered 57 epirubicin cisplatin 57 μg 57 secondary efficacy endpoint 57 ipsilateral stroke 57 Pioglitazone 57 nucleoside reverse transcriptase inhibitor 57 NSABP B 57 #.#mg 1mg 57 MIC# [001] 57 topotecan 57 fumarate 57 carboplatin chemotherapy 57 EUFLEXXA R 57 carboplatin 57 darunavir r 57 vilanterol 57 mg Lucentis 57 acute bipolar mania 56 Relapsed Refractory 56 Hydrochlorothiazide 56 rifabutin 56 #ug [002] 56 boosted protease inhibitor 56 vandetanib #mg 56 5 fluorouracil leucovorin 56 ergot derivatives 56 hypertrichosis occurred 56 induction regimen 56 BUPHENYL 56 angiotensin converting enzyme inhibitor 56 activated partial thromboplastin 56 immunomodulatory therapy 56 alanine aminotransferase ALT 56 mL kg 56 nebulized formoterol fumarate 56 Melphalan 56 tiotropium 56 Sitagliptin 56 azilsartan medoxomil 56 epirubicin 56 pyrimidine nucleoside analog 56 mometasone 56 mg FV 56 maximally tolerated dose 56 sunitinib Sutent 56 ACTOplus met XR 56 Platinol ® 56 Enoxaparin 56 cinacalcet 56 ABVD 56 events SAEs 56 dihydrochloride 56 humanized interleukin 6 56 beclomethasone 56 orally administered inhibitor 56 alpha 2b 56 fasting plasma glucose FPG 56 iodixanol 56 cholestyramine 56 metformin IR 56 chills fever headache 56 HBeAg negative 56 fraction LVEF 56 tacrolimus capsules 56 metformin HCl 56 locoregional recurrence 56 Soriatane R 56 HCV genotype 56 Adverse events 56 #mg #mg [001] 56 dose dose escalation 56 ganciclovir 56 CK # administered 56 subcutaneously 56 chemotherapy FOLFOX 56 remission induction 56 anthracycline containing 56 Telithromycin 56 arsenic trioxide injection 56 Pharmacokinetic parameters 56 virologic response 56 Taxotere chemotherapy 56 reinfarction 56 mg iv peramivir 56 infusional 56 Rating Scale MADRS 56 INVANZ 56 Secondary endpoints included 56 detemir 56 mCi m 2 56 recurrent genital herpes 56 sapropterin dihydrochloride 56 CTAP# Capsules 56 diarrhea nausea vomiting 56 radiochemotherapy 56 lopinavir ritonavir 56 ARIKACE 56 indinavir 56 captopril 56 tinidazole 56 tazobactam 56 vincristine doxorubicin 56 hour bronchodilation 56 idraparinux 56 FOLFOX6 chemotherapy regimen 56 rapid virologic response 56 Intravitreal 56 Sanofi Pasteur Fluzone 56 randomized #:#:# 56 potent triglyceride lowering 56 metastatic renal cell carcinoma 56 infusional 5-FU/LV 56 mycophenolic acid 56 demonstrated antitumor activity 56 Patients Treated With 56 REBETOL 56 STELARA ® 56 acarbose 56 REYATAZ R 56 #mg dose [001] 56 Vildagliptin 56 AUC0 56 cisplatin carboplatin 56 pooled comparator 56 Nebulized 56 intradermally 56 Benazepril 56 corticosteroid dexamethasone 56 adjunctive ABILIFY 56 Navelbine ® 56 zoledronic acid 56 severe hypersensitivity reactions 56 ELOXATIN 56 pyridostigmine 56 etoposide 56 cGy 56 mL/min/#.# m 2 56 Pravachol pravastatin 56 gemcitabine Gemzar 56 terfenadine 56 gemcitabine chemotherapy 56 aplindore 56 imiquimod cream 56 Inhalation Aerosol 56 rHuEPO 56 μg ml 56 urinary N telopeptide 56 PegIntron 56 Cmax 56 Fluconazole 56 sulfonylurea metformin 56 PREZISTA r arm 56 achieved CCyR 56 PROCTOCORT ® Cream Hydrocortisone 56 stage IIIB 56 Diovan Exforge Tekturna Zelnorm 56 bortezomib refractory 56 losartan potassium 56 5mg #mg #mg 56 evaluable 56 KAPIDEX 56 posaconazole 56 leucovorin 56 neutropaenia 56 Dosed 56 HCV RESPOND 2 56 undetectable virus HCV 56 mg/# mg [001] 56 haematologic 56 leukocyte count 56 trough FEV1 56 Nilotinib 56 sorafenib tablets 56 mIU mL 56 nebulization 56 median PFS 56 GEMZAR 56 mg doses 56 Kinoid 56 salmeterol fluticasone propionate 56 HBsAg 56 cEVR 56 XIENCE V PROMUS Stent 56 x ULN 56 hematologic toxicity 56 leuprorelin 56 myelodysplastic myeloproliferative diseases 56 mEq L 56 channel blocker amlodipine 56 MADRS score 56 genotypic resistance 56 PROCRIT 56 vitamin D2 56 splenectomized 56 endoscopic remission 56 venlafaxine Effexor 56 docetaxel Taxotere 56 DMARDs 56 mg 56 alefacept 56 levofloxacin 56 subcutaneously injected 56 Azacitidine 56 degarelix 56 FASLODEX 56 events MACE 56 CLINICAL STUDIES 56 methotrexate monotherapy 56 xanthine oxidase inhibitor 56 zafirlukast 56 underwent surgical resection 56 bendamustine 56 fluvastatin 56 hydrochlorothiazide HCTZ 56 balsalazide disodium Capsules 56 TMC# r 56 administering XIFAXAN 56 BENICAR HCT 56 Announces Tentative Approval 56 decitabine 56 ropivacaine 56 3TC lamivudine 56 ramipril Altace 56 #:# randomization 56 nmol liter 56 myopathy rhabdomyolysis 56 events TEAEs 56 pruritus itching 56 ACE inhibitor benazepril 56 1mg 56 peripheral sensory neuropathy 56 KRAS mutations occur 56 Rhinocort 56 oral amoxicillin 56 non inferiority 56 aPTT 56 Natalizumab 56 Darunavir 56 plus medroxyprogesterone acetate 55 diclofenac Voltaren